This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Clovis Oncology Inc (CLVS)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 278.76M 482.68M 323.23M 144.10M
Receivables 5.28M 0.00 3.87M 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 199.00K 4.73M 0.00 659.00K
Total Current Assets 539.70M 491.17M 328.60M 144.87M
Property, Plant & Equipment, Gross 6.74M 3.79M 1.68M 1.59M
Accumulated Depreciation & Depletion 1.79M 1.07M 728.00K 508.00K
Property, Plant & Equipment, Net 4.95M 2.72M 955.00K 1.08M
Intangibles 123.34M 212.90M 244.52M 0.00
Other Non-Current Assets -13.93M 13.36M 755.00K 38.00K
Total Non-Current Assets 173.69M 295.03M 321.04M 1.12M
Liabilities & Shareholder Equity
Total Assets 713.39M 786.21M 649.63M 145.99M
Accounts Payable 11.26M 2.92M 4.42M 2.30M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 411.00K 0.00 0.00
Total Current Liabilities 75.58M 47.77M 20.95M 12.16M
Long Term Debt 279.88M 287.50M 0.00 0.00
Deferred Income Taxes 31.13M 66.85M 74.95M 0.00
Other Non-Current Liabilities 26.14M 52.45M 55.84M 338.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 337.16M 406.80M 130.80M 338.00K
Total Liabilities 412.74M 454.58M 151.75M 12.50M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 300.65M 331.63M 497.89M 133.50M
Common Par 38.00K 34.00K 34.00K 26.00K
Additional Paid In Capital 1.13B 785.09M 762.17M 317.90M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -781.91M -429.05M -269.01M -184.48M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -47.46M -24.45M 4.70M 53.00K
Total Capitalization 580.53M 619.13M 497.89M 133.50M
Total Equity 300.65M 331.63M 497.89M 133.50M
Total Liabilities & Stock Equity 713.39M 786.21M 649.63M 145.99M
Total Common Shares Outstanding 38.36M 33.98M 33.90M 26.21M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 36.03M 33.89M 28.67M 24.91M
Diluted Weighted Shares Outstanding 36.03M 33.89M 28.67M 24.91M
Number of Employees 309 136 74 61
Number of Part-Time Employees 0 0 0 0
CLVS News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

CLVS Clovis Oncology Inc

Chart of CLVS

Analysts Ratings for CLVS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 3 3 3
Moderate Buy 0 0 0 0
Hold 4 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CLVS ANALYST REPORT

CLVS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs